AMENDMENT NO. 1 TO CONSULTING SERVICES AGREEMENT
Exhibit 10.27
AMENDMENT NO. 1
TO
This Amendment No. 1 (“Amendment”) is entered into as of September 1, 2023 ("Effective Date") by and between Board Advantage LLC, with an address of 000 Xxxxxxx Xxxx, Xxxxxxx Xxxxxxx, XX 00000 ("Consultant"), and Akari Therapeutics, Inc. located at 00 Xxxxxx Xxxxx Xxxx, Xx 0, Xxxxxx, XX 00000 ("Akari"), and amends the Consulting Agreement dated July 17, 2023 between Akari and Consultant. Consultant and Xxxxx are each referred to individually as a "Party" and together as the "Parties.” Capitalized terms shall have the meanings ascribed in the Agreement unless otherwise noted herein.
WHEREAS Xxxxx and Consultant desire to modify the Consulting Agreement;
NOW, THEREFORE, in consideration of the promises and mutual covenants set forth herein, the Parties agree as follows:
Agreed to and accepted by:
AKARI THERAPEUTICS, INC. |
|
BOARD ADVANTAGE, LLC |
||||
|
|
|
|
|
|
|
By: |
|
/s/ Xxxxxxxx Xxxxxxx |
|
By: |
|
/s/ Xxxxx XxXxxxx |
|
|
|
|
|
|
|
Printed Name: |
|
Xxxxxxxx Xxxxxxx |
|
Printed Name: |
|
Xxxxx XxXxxxx |
|
|
|
|
|
|
|
Title |
|
President and CEO |
|
Title: |
|
Interim CFO |
|
|
|
|
|
|
|
Date: |
|
09/27/23 |
|
Date: |
|
09/27/23 |